India's Clean Science and Technology slips; Dolat Capital starts coverage with 'buy'
** Shares of Clean Science and Technology CLEA.NS down 3.5% at 740.05 rupees ** Dolat Capital initiates coverage on CLEA with "buy" rating ** Brokerage sets price target at 1,105 rupees, implying around 44% upside to previous close ** CLEA's fourth-quarter revenue, EBITDA, and profit beat consensus estimates on improved volume performance, brokerage says in a note ** "Legacy business also appears to have bottomed out, with improving visibility on volume growth," Dolat Capital says ** CLEA stock down ~15%, YTD (Reporting by Vijay Malkar) ((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Clean Science and Technology
See all newsBrief: Clean Science And Technology Says Search And Seizure Proceedings By Maharashtra GST Department Concluded On Sept 29, 2026
Brief: Clean Science And Technology Says Tax Department Initiates Search And Seizure At Clean Science On Sept 23
Brief: Clean Science And Technology Says Unit Enters Long-Term Strategic Collaboration With Geneus Chem AG
India's Clean Science and Technology slips; Dolat Capital starts coverage with 'buy'
Brief: Clean Science And Technology March-Quarter Consol Profit 582.7 Million Rupees